Búsqueda | Biblioteca Virtual en Salud

1.

Primary Neural Degeneration in the Human Cochlea: Evidence for Hidden Hearing Loss in the Aging Ear.

Wu, P Z; Liberman, L D; Bennett, K; de Gruttola, V; O'Malley, J T; Liberman, M C.

Neuroscience ; 407: 8-20, 2019 05 21.

Artículo en Inglés | MEDLINE | ID: mdl-30099118

2.

The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine.

Jacobson, M A; De Gruttola, V; Reddy, M; Arduino, J M; Strickland, S; Reichman, R C; Bartlett, J A; Phair, J P; Hirsch, M S; Collier, A C.

AIDS ; 9(7): 727-34, 1995 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-7546418

3.

Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study Group.

Goebel, F D; Mannhalter, J W; Belshe, R B; Eibl, M M; Grob, P J; de Gruttola, V; Griffiths, P D; Erfle, V; Kunschak, M; Engl, W.

AIDS ; 13(12): 1461-8, 1999 Aug 20.

Artículo en Inglés | MEDLINE | ID: mdl-10465068

4.

Estimating prevalence of HIV infection: considerations in the design and analysis of a national seroprevalence survey.

De Gruttola, V; Fineberg, H V.

J Acquir Immune Defic Syndr (1988) ; 2(5): 472-80, 1989.

Artículo en Inglés | MEDLINE | ID: mdl-2795449

5.

The conditional latency distribution of AIDS for persons infected by blood transfusion.

Lagakos, S W; De Gruttola, V.

J Acquir Immune Defic Syndr (1988) ; 2(1): 84-7, 1989.

Artículo en Inglés | MEDLINE | ID: mdl-2918463

6.

Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex.

De Gruttola, V; Wulfsohn, M; Fischl, M A; Tsiatis, A.

J Acquir Immune Defic Syndr (1988) ; 6(4): 359-65, 1993 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-8095980

7.

A model for the AIDS epidemic in Mexico: short-term projections.

Mohar, A; De Gruttola, V; Mueller, N; Sepúlveda, J.

J Acquir Immune Defic Syndr (1988) ; 5(3): 265-70, 1992.

Artículo en Inglés | MEDLINE | ID: mdl-1740752

8.

Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens.

Gilbert, P B; Hanna, G J; De Gruttola, V; Martinez-Picado, J; Kuritzkes, D R; Johnson, V A; Richman, D D; D'Aquila, R T.

AIDS Res Hum Retroviruses ; 16(14): 1325-36, 2000 Sep 20.

Artículo en Inglés | MEDLINE | ID: mdl-11018852

9.

AIDS risk.

De Gruttola, V; Lagakos, S W.

Science ; 241(4864): 399, 1988 Jul 22.

Artículo en Inglés | MEDLINE | ID: mdl-3393904

10.

Why are the decay rates in plasma HIV-1 different for different treatments and in different patient populations?

Wu, H; Ding, A A; De Gruttola, V.

AIDS ; 13(3): 429-30, 1999 Feb 25.

Artículo en Inglés | MEDLINE | ID: mdl-10199240

11.

Modelling progression of CD4-lymphocyte count and its relationship to survival time.

De Gruttola, V; Tu, X M.

Biometrics ; 50(4): 1003-14, 1994 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-7786983

12.

Characterizing the relationship between HIV-1 genotype and phenotype: prediction-based classification.

Foulkes, A S; De, Gruttola V.

Biometrics ; 58(1): 145-56, 2002 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-11890310

13.

Assessing and modeling heterosexual spread of the human immunodeficiency virus in the United States.

De Gruttola, V; Mayer, K H.

Rev Infect Dis ; 10(1): 138-50, 1988.

Artículo en Inglés | MEDLINE | ID: mdl-3353626

14.

Analysis of doubly-censored survival data, with application to AIDS.

De Gruttola, V; Lagakos, S W.

Biometrics ; 45(1): 1-11, 1989 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-2497809

15.

Strategies for cohort sampling under the Cox proportional hazards model, application to an AIDS clinical trial.

Kim, S; De Gruttola, V.

Lifetime Data Anal ; 5(2): 149-72, 1999 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-10408182

16.

The value of AIDS incidence data in assessing the spread of HIV infection.

De Gruttola, V; Lagakos, S W.

Stat Med ; 8(1): 35-43, 1989 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-2919246

17.

AIDS: has the problem been adequately assessed?

De Gruttola, V; Mayer, K; Bennett, W.

Rev Infect Dis ; 8(2): 295-305, 1986.

Artículo en Inglés | MEDLINE | ID: mdl-3704455

18.

Estimating the proportion of treatment effect explained by a surrogate marker.

Lin, D Y; Fleming, T R; De Gruttola, V.

Stat Med ; 16(13): 1515-27, 1997 Jul 15.

Artículo en Inglés | MEDLINE | ID: mdl-9249922

19.

Estimation of HIV dynamic parameters.

Wu, H; Ding, A A; De Gruttola, V.

Stat Med ; 17(21): 2463-85, 1998 Nov 15.

Artículo en Inglés | MEDLINE | ID: mdl-9819839

20.

Assessment of non-response bias in a probability household survey of male same-gender sexual behavior.

Izazola-Licea, J A; Gortmaker, S L; De Gruttola, V; Tolbert, K; Mann, J.

Salud Publica Mex ; 42(2): 90-8, 2000.

Artículo en Inglés | MEDLINE | ID: mdl-10893978

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Primary Neural Degeneration in the Human Cochlea: Evidence for Hidden Hearing Loss in the Aging Ear.

The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine.

Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study Group.

Estimating prevalence of HIV infection: considerations in the design and analysis of a national seroprevalence survey.

The conditional latency distribution of AIDS for persons infected by blood transfusion.

Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex.

A model for the AIDS epidemic in Mexico: short-term projections.

Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens.

AIDS risk.

Why are the decay rates in plasma HIV-1 different for different treatments and in different patient populations?

Modelling progression of CD4-lymphocyte count and its relationship to survival time.

Characterizing the relationship between HIV-1 genotype and phenotype: prediction-based classification.

Assessing and modeling heterosexual spread of the human immunodeficiency virus in the United States.

Analysis of doubly-censored survival data, with application to AIDS.

Strategies for cohort sampling under the Cox proportional hazards model, application to an AIDS clinical trial.

The value of AIDS incidence data in assessing the spread of HIV infection.

AIDS: has the problem been adequately assessed?

Estimating the proportion of treatment effect explained by a surrogate marker.

Estimation of HIV dynamic parameters.

Assessment of non-response bias in a probability household survey of male same-gender sexual behavior.